High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion (original) (raw)
Keeshan K, Mills KI, Cotter TG, McKenna SL . Elevated Bcr-Abl levels are sufficient for a haematopoietic cell line to acquire a drug resistant phenotype Leukemia 2001 15: 1823–1833 ArticleCASPubMed Google Scholar
Amarante-Mendes GP, McGahon AJ, Nishioka WK, Afar DE, Witte ON, Green DR . Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL Oncogene 1998 16: 1383–1390 ArticleCASPubMed Google Scholar
McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG . BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15; 83(12): 3835] Blood 1994 83: 1179–1187 CASPubMed Google Scholar
Oetzel C, Jonuleit T, Gotz A, van der Kuip H, Michels H, Duyster J, Hallek M, Aulitzky WE . The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X Clin Cancer Res 2000 6: 1958–1968 CASPubMed Google Scholar
Di Bacco A, Keeshan K, McKenna SL, Cotter TG . Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis Oncologist 2000 5: 405–415 ArticleCASPubMed Google Scholar
Wilson-Rawls J, Liu J, Laneuville P, Arlinghaus RB . P210 Bcr-Abl interacts with the interleukin-3 beta c subunit and constitutively activates Jak2 Leukemia 1997 11 (Suppl. 3): 428–431 Google Scholar
Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE, Arlinghaus RB . Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation Oncogene 2001 20: 6188–6195 ArticleCASPubMed Google Scholar
Sakai I, Kraft AS . The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells J Biol Chem 1997 272: 12350–12358 ArticleCASPubMed Google Scholar
de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells Blood 1999 94: 1108–1112 CASPubMed Google Scholar
Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T . Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis J Exp Med 1999 189: 1229–1242 ArticleCASPubMedPubMed Central Google Scholar
Gesbert F, Griffin JD . Bcr/Abl activates transcription of the Bcl-X gene through STAT5 Blood 2000 96: 2269–2276 CASPubMed Google Scholar
Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B . Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway EMBO J 1997 16: 6151–6161 ArticleCASPubMedPubMed Central Google Scholar
Mathieu AL, Gonin S, Leverrier Y, Blanquier B, Thomas J, Dantin C, Martin G, Baverel G, Marvel J . Activation of the phosphatidylinositol 3-kinase/Akt pathway protects against interleukin-3 starvation but not DNA damage-induced apoptosis J Biol Chem 2001 276: 10935–10942 ArticleCASPubMed Google Scholar
Rosa Santos SC, Dumon S, Mayeux P, Gisselbrecht S, Gouilleux F . Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3- dependent survival of a bone marrow derived cell line Oncogene 2000 19: 1164–1172 ArticleCASPubMed Google Scholar
Salomoni P, Condorelli F, Sweeney SM, Calabretta B . Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects Blood 2000 96: 676–684 CASPubMed Google Scholar
Salomoni P, Wasik MA, Riedel RF, Reiss K, Choi JK, Skorski T, Calabretta B . Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant J Exp Med 1998 187: 1995–2007 ArticleCASPubMedPubMed Central Google Scholar
Neshat MS, Raitano AB, Wang HG, Reed JC, Sawyers CL . The survival function of the Bcr-Abl oncogene is mediated by Bad- dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf Mol Cell Biol 2000 20: 1179–1186 ArticleCASPubMedPubMed Central Google Scholar
Majewski M, Nieborowska-Skorska M, Salomoni P, Slupianek A, Reiss K, Trotta R, Calabretta B, Skorski T . Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt Cancer Res 1999 59: 2815–2819 CASPubMed Google Scholar
Jia L, Patwari Y, Srinivasula SM, Newland AC, Fernandes-Alnemri T, Alnemri ES, Kelsey SM . Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis Oncogene 2001 20: 4817–4826 ArticleCASPubMed Google Scholar
Gonzalez-Garcia M, Perez-Ballestero R, Ding L, Duan L, Boise LH, Thompson CB, Nunez G . bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria Development 1994 120: 3033–3042 CASPubMed Google Scholar
Gross A, Jockel J, Wei MC, Korsmeyer SJ . Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis EMBO J 1998 17: 3878–3885 ArticleCASPubMedPubMed Central Google Scholar
Hsu YT, Wolter KG, Youle RJ . Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis Proc Natl Acad Sci USA 1997 94: 3668–3672 ArticleCASPubMedPubMed Central Google Scholar
Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ . Movement of Bax from the cytosol to mitochondria during apoptosis J Cell Biol 1997 139: 1281–1292 ArticleCASPubMedPubMed Central Google Scholar
Oliver L, Priault M, Tremblais K, LeCabellec M, Meflah K, Manon S, Vallette FM . The substitution of the C-terminus of bax by that of bcl-xL does not affect its subcellular localization but abrogates its pro-apoptotic properties FEBS Lett 2000 487: 161–165 ArticleCASPubMed Google Scholar
Nouraini S, Six E, Matsuyama S, Krajewski S, Reed JC . The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-X(L) Mol Cell Biol 2000 20: 1604–1615 ArticleCASPubMedPubMed Central Google Scholar
Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ . BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity J Biol Chem 1997 272: 24101–24104 ArticleCASPubMed Google Scholar
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME . Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 1997 91: 231–241 ArticleCASPubMed Google Scholar
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ . Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14–3-3 not BCL-X(L) Cell 1996 87: 619–628 ArticleCASPubMed Google Scholar
Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM . Conversion of Bcl-2 to a Bax-like death effector by caspases Science 1997 278: 1966–1968 ArticleCASPubMed Google Scholar
Harris MH, Thompson CB . The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability Cell Death Differ 2000 7: 1182–1191 ArticleCASPubMed Google Scholar
Shimizu S, Tsujimoto Y . Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity Proc Natl Acad Sci USA 2000 97: 577–582 ArticleCASPubMedPubMed Central Google Scholar
Polster BM, Kinnally KW, Fiskum G . Bh3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability J Biol Chem 2001 276: 37887–37894 CASPubMed Google Scholar
Bossy-Wetzel E, Newmeyer DD, Green DR . Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization EMBO J 1998 17: 37–49 ArticleCASPubMedPubMed Central Google Scholar
Martinou JC, Green DR . Breaking the mitochondrial barrier Nat Rev Mol Cell Biol 2001 2: 63–67 ArticleCASPubMed Google Scholar
Guinn BA, Evely RS, Walsh V, Gilkes AF, Burnett AK, Mills KI . An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells Leuk Lymphoma 2000 37: 393–404 ArticleCASPubMed Google Scholar
Gisslinger H, Kurzrock R, Wetzler M, Tucker S, Kantarjian H, Robertson B, Talpaz M . Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences Leuk Lymphoma 1997 25: 121–133 ArticleCASPubMed Google Scholar
Liu RY, Fan C, Garcia R, Jove R, Zuckerman KS . Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines Blood 1999 93: 2369–2379 CASPubMed Google Scholar
Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM . Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor Nature 1996 379: 645–648 ArticleCASPubMed Google Scholar
Tang X, Downes CP, Whetton AD, Owen-Lynch PJ . Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase J Biol Chem 2000 275: 13142–13148 ArticleCASPubMed Google Scholar
Sun X, Layton JE, Elefanty A, Lieschke GJ . Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL--expressing cells, demonstrating synergy between AG490 and STI571 Blood 2001 97: 2008–2015 ArticleCASPubMed Google Scholar
Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS, Green DR . Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death Cell Death Differ 1998 5: 298–306 ArticleCASPubMed Google Scholar
Craddock BL, Orchiston EA, Hinton HJ, Welham MJ . Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling J Biol Chem 1999 274: 10633–10640 ArticleCASPubMed Google Scholar
Ilaria RL Jr, Van Etten RA . P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members J Biol Chem 1996 271: 31704–31710 ArticleCASPubMed Google Scholar
Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ . Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death Science 2001 292: 727–730 ArticleCASPubMedPubMed Central Google Scholar
Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ . Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death Cell 1995 80: 285–291 ArticleCASPubMed Google Scholar
Nechushtan A, Smith CL, Hsu YT, Youle RJ . Conformation of the Bax C-terminus regulates subcellular location and cell death EMBO J 1999 18: 2330–2341 ArticleCASPubMedPubMed Central Google Scholar
Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M, Lock RB . Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells Cell Death Differ 2000 7: 102–111 ArticleCASPubMed Google Scholar
Zhou XM, Liu Y, Payne G, Lutz RJ, Chittenden T . Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155 J Biol Chem 2000 275: 25046–25051 ArticleCASPubMed Google Scholar